Generali Investments Towarzystwo Funduszy Inwestycyjnych
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2043130
WARSAW, R9
Position in VRTX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$844,441
-$93,293 QoQ
Shares Held
1,700
-19.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#900
of 1,732 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Generali Investments Towarzystwo Funduszy Inwestycyjnych holds $5,668,680 across 7 Biotechnology names. VRTX ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
20,500 | $1,448,325 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,400 | $872,956 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,700 | $844,441 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
15,000 | $818,100 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
22,000 | $755,040 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
40,000 | $676,800 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,050 | $253,018 |
All Filings in VRTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $844,441 | 1,700 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $937,734 | 2,100 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $952,056 | 2,100 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $822,444 | 2,100 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $534,240 | 1,200 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $581,784 | 1,200 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $483,240 | 1,200 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||